SINGLE CENTRE SURVIVAL OUTCOMES IN THE TREATMENT OF INTERMEDIATE AND HIGH-RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKAEMIA WITH 5-AZACITIDINE

被引：0
|
作者：
Stringer, R. [1 ]
Rider, D. T. [2 ]
Newman, D. J. [2 ]
Grace, D. R. [2 ]
机构：
[1] Brighton & Sussex Med Sch, Brighton, E Sussex, England
[2] East Sussex Healthcare NHS Trust, Eastbourne, England
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1835
引用
收藏
页码：725 / 726
页数：2
相关论文
共 50 条
  • [41] NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia
    Miller, Whitney
    Holden, Joanne
    George, Elisabeth
    Stein, Ken
    LANCET ONCOLOGY, 2011, 12 (04): : 326 - 327
  • [42] Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoecker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    BLOOD, 2014, 124 (21)
  • [43] Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia
    Wei, Andrew
    Tan, Peter
    Perruzza, Sarah
    Govindaraj, Chindu
    Fleming, Shaun
    McManus, Julie
    Avery, Sharon
    Patil, Sushrut
    Stevenson, William
    Plebanski, Magdalena
    Spencer, Andrew
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (02) : 199 - 210
  • [44] 5-Azacitidine Therapy in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia: a Single Institution Experience
    Freyrie, Alessandra
    Reda, Gianluigi
    Vincenti, Daniele
    Sciume, Mariarita
    Binda, Francesca
    Guidotti, Francesca
    Cortelezzi, Agostino
    BLOOD, 2012, 120 (21)
  • [45] SEQUENTIAL ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME: EXPERIENCE FROM A SINGLE CENTRE
    Jurado, Rebeca
    Morgades, Mireia
    de Jaureguizar, Alejandro
    Canelo, Marta
    Xicoy, Blanca
    Vives, Susana
    Josefa Jimenez, Maria
    Huguet, Maria
    Ferra, Christelle
    Maria Ribera, Josep
    Manuel Sancho, Juan
    Torrent, Anna
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 258 - 259
  • [46] Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study
    Merkel, Drorit
    Filanovsky, Kalman
    Gafter-Gvili, Anat
    Vidal, Liat
    Aviv, Ariel
    Gatt, Moshe E.
    Silbershatz, Itay
    Herishanu, Yair
    Arad, Ariela
    Tadmor, Tamar
    Dally, Najib
    Nemets, Anatoly
    Rouvio, Ory
    Ronson, Aharon
    Herzog-Tzarfati, Katrin
    Akria, Luiza
    Braester, Andrei
    Hellmann, Ilana
    Yeganeh, Shay
    Nagler, Arnon
    Leiba, Ronit
    Mittelman, Moshe
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (02) : 130 - 134
  • [47] Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Pasvolsky, Oren
    Saliba, Rima M.
    Popat, Uday R.
    Alousi, Amin
    Mehta, Rohtesh
    Yeh, Jason
    Al-Atrash, Gheath
    Adeel, Masood
    Ramdial, Jeremy
    Marin, David
    Rondon, Gabriela
    Kebriaei, Partow
    Champlin, Richard
    Daver, Naval
    Dinardo, Courtney
    Short, Nicholas J.
    Shpall, Elizabeth J.
    Oran, Betul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05): : e196 - e204
  • [48] Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
    Pappa, V.
    Papageorgiou, S.
    Tsirigotis, P.
    Dervenoulas, J.
    Girkas, K.
    Papageorgiou, E.
    Poulakidas, H.
    Papadaki, E.
    Galanopoulos, A.
    Vervessou, E.
    Panayotidis, P.
    Zomas, A.
    Symeonidis, A.
    Economopoulos, T.
    LEUKEMIA RESEARCH, 2009, 33 : S134 - S135
  • [49] Outcomes of the patients with myelodysplastic syndrome, acute myeloid leukaemia with multilineage dysplasia and treatment-related acute myeloid leukaemia after allogeneic stem cell transplantation. A single-centre experience
    Steinerova, K.
    Koza, V.
    Jindra, P.
    Lysak, D.
    Karas, M.
    Svoboda, T.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S189 - S189
  • [50] ACUTE MYELOID LEUKEMIA WITH INV(16) TO TREATMENT WITH 5-AZACITIDINE ON THE BASIS OF A CASE
    Lopez Diaz, M.
    Cuenca Aprell, C. A.
    Iglesias Varela, R.
    Albors Ferreiro, M.
    Sastre Moral, J. L.
    HAEMATOLOGICA, 2017, 102 : 166 - 167
12345